ACTA1 and idiopathic pulmonary fibrosis: Importantly, protein expression of the myofibroblast marker α-SMA could be significantly reduced in IPF-fibroblasts after treatment with LBH589 or pirfenidone, in comparison to vehicle (Fig 7D).